SCIENTURE HOLDINGS, INC. Derivative Liability
SCIENTURE HOLDINGS, INC. (SCNX) had Derivative Liability of $2.36 million as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2025-11-12
- 2025-06-30: Derivative Liability $2.36M.
- 2025-03-31: Derivative Liability $1.69M.
- 2024-12-31: Derivative Liability $2.30M.
| Period end | Derivative Liability |
|---|---|
| 2025-06-30 | $2.36M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.69M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $2.30M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |